Dimerix Limited (ASX:DXB)
Australia · Delayed Price · Currency is AUD 0.5150
-0.0100 (-1.90%)
Feb 5, 2026, 4:10 PM AEST
Dimerix Market Cap
Dimerix has a market cap or net worth of 309.2 million as of February 5, 2026. Its market cap has increased by 15.46% in one year.
Market Cap
309.20M
Enterprise Value
241.02M
Revenue
5.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.52
Market Cap Chart
Since July 6, 2015, Dimerix's market cap has increased from 13.24M to 309.20M, an increase of 2,236.02%. That is a compound annual growth rate of 34.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 309.20M | -6.36% |
| Dec 31, 2025 | 330.22M | 74.10% |
| Dec 31, 2024 | 189.67M | 117.15% |
| Dec 29, 2023 | 87.35M | 87.74% |
| Dec 30, 2022 | 46.53M | -40.82% |
| Dec 31, 2021 | 78.61M | 69.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Opthea | 738.77M |
| Immutep | 589.49M |
| Clinuvel Pharmaceuticals | 562.75M |
| Racura Oncology | 408.36M |
| Orthocell | 259.10M |
| Botanix Pharmaceuticals | 206.86M |
| Tetratherix | 203.06M |
| Starpharma Holdings | 176.36M |